CMOPF (Cosmo NV) FFO


CMOPF Cosmo NV CMOPF
82 GF Score
Price $84.73
GF Value $54.86
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cosmo NV FFO?

FFO (Funds from operations) only applies to REITs.

CMOPF
82GF Score
Cosmo NV CMOPF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cosmo NV (CMOPF) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued. The current stock price of $84.73 is trading 54.4% above its estimated GF Value™ of $54.86. GuruFocus considers Cosmo NV to be Significantly Overvalued.

Key valuation signals for CMOPF:

  • FFO:
  • GF Value™: $54.86 vs. price of $84.73 (54.4% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the CMOPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo NV Business Description

Address 91/94 North Wall Quay, 7th Floor, One North Dock, Dublin, IRL, D01 H7V7
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
82GF Score

Get the complete analysis for CMOPF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$84.73
Price
$54.86
GF Value